drugset / Trial / NCT03461575
Efficacy and Safety of HU007 Eye Drops in Patients With Dry Eye Syndrome
RandomizedFactorialDouble-blindTreatment
Summary
A multicenter, Randomized, Double blind, Restasis®-controlled Non-inferiority, Moisview® Eye Drops-controlled Superiority, Phase III Study to Evaluate the Efficacy and Safety of HU007 Eye Drops in Patients with Dry Eye Syndrome
Timeline
- Start
- 2018-01-22
- Primary completion
- 2018-07-12
- Completion
- 2018-07-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclosporine | Peptide | 0.02 % | Other |
| Subject | Cyclosporine | Peptide | 0.05 % | Other |
| Subject | Trehalose | Small molecule | 3 % | Other |